These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288 [TBL] [Abstract][Full Text] [Related]
3. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798 [TBL] [Abstract][Full Text] [Related]
4. Can Melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma? Kucher C; Zhang PJ; Acs G; Roberts S; Xu X Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):324-7. PubMed ID: 16932024 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis. Hitchcock MG; McCalmont TH; White WL Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704 [TBL] [Abstract][Full Text] [Related]
6. Acral lentiginous melanoma: an immunohistochemical study of 20 cases. Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody. Fernando SS; Johnson S; Bäte J Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017 [TBL] [Abstract][Full Text] [Related]
8. A metastatic melanoma with an unusual immunophenotypic profile. Gao Z; Stanek A; Chen S Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440 [TBL] [Abstract][Full Text] [Related]
9. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961 [TBL] [Abstract][Full Text] [Related]
10. False-positive cells in sentinel lymph nodes. Brennick JB; Yan S Semin Diagn Pathol; 2008 May; 25(2):116-9. PubMed ID: 18697715 [TBL] [Abstract][Full Text] [Related]
11. Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes. Jungbluth AA Semin Diagn Pathol; 2008 May; 25(2):120-5. PubMed ID: 18697716 [TBL] [Abstract][Full Text] [Related]
12. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376 [TBL] [Abstract][Full Text] [Related]
13. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Baisden BL; Askin FB; Lange JR; Westra WH Am J Surg Pathol; 2000 Aug; 24(8):1140-6. PubMed ID: 10935655 [TBL] [Abstract][Full Text] [Related]
14. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069 [TBL] [Abstract][Full Text] [Related]
15. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes. Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770 [TBL] [Abstract][Full Text] [Related]
16. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. El Shabrawi-Caelen L; Kerl H; Cerroni L Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366 [TBL] [Abstract][Full Text] [Related]
17. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes. Willis BC; Johnson G; Wang J; Cohen C Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946 [TBL] [Abstract][Full Text] [Related]
18. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510 [TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration. Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358 [TBL] [Abstract][Full Text] [Related]